GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CareDx Inc (FRA:1K9) » Definitions » Total Liabilities

CareDx (FRA:1K9) Total Liabilities : €180.5 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is CareDx Total Liabilities?

CareDx's Total Liabilities for the quarter that ended in Mar. 2024 was €180.5 Mil.

CareDx's quarterly Total Liabilities increased from Sep. 2023 (€100.30 Mil) to Dec. 2023 (€188.44 Mil) but then declined from Dec. 2023 (€188.44 Mil) to Mar. 2024 (€180.49 Mil).

CareDx's annual Total Liabilities increased from Dec. 2021 (€89.16 Mil) to Dec. 2022 (€105.80 Mil) and increased from Dec. 2022 (€105.80 Mil) to Dec. 2023 (€188.44 Mil).


CareDx Total Liabilities Historical Data

The historical data trend for CareDx's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CareDx Total Liabilities Chart

CareDx Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.46 74.66 89.16 105.80 188.44

CareDx Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 101.06 101.17 100.30 188.44 180.49

CareDx Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

CareDx's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=71.592+(25.931+88.538
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+2.381+0)
=188.4

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=428.079-239.638
=188.4

CareDx's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=64.594+(24.742+89.871
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+1.28+0)
=180.5

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=416.214-235.727
=180.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CareDx Total Liabilities Related Terms

Thank you for viewing the detailed overview of CareDx's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


CareDx (FRA:1K9) Business Description

Traded in Other Exchanges
Address
8000 Marina Boulevard, Brisbane, CA, USA, 94005
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. Its primary operations are in Brisbane, California; Omaha, Nebraska; Fremantle, Australia and Stockholm, Sweden.

CareDx (FRA:1K9) Headlines

No Headlines